Valbenazine tosylate (NBI-98854; NBI98854; MT5199; MT-5199), the tosylate salt of valbenazine, is a VMAT2 (vesicular monoamine transporter 2) inhibitor approved in 2017 by FDA for the treatment of TD/tardive dyskinesia (uncontrollable movement of the face, tongue, or other body parts).
Tags: buy Valbenazine tosylate | Valbenazine tosylate supplier | purchase Valbenazine tosylate | Valbenazine tosylate cost | Valbenazine tosylate manufacturer | order Valbenazine tosylate | Valbenazine tosylate distributor